| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Johnson & Johnson (JNJ) has 22 insiders with recent SEC Form 4 filings, including 1 buy and 19 sells. JNJ is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.04M | $899.13M | - | |
| VP | 194.4K | $43.25M | - | |
| CEO | 79.6K | $17.72M | - | |
| VP | 46.2K | $10.28M | - | |
| VP | 32.5K | $7.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Reed John C | EVP, Innovative Medicine, R&D | Sale+OE | 53,931 | $243.00 | $13,105,233.00 | -59.6% | - | - | |
| Feb 17, 2026 | Swanson James D. | EVP, CIO | Sale+OE | 62,080 | $243.39 | $15,109,758.99 | -45.0% | - | - | |
| Feb 17, 2026 | Wolk Joseph J | Exec VP, CFO | Sale+OE | 89,654 | $242.80 | $21,767,826.99 | -40.7% | - | - | |
| Jan 26, 2026 | Duato Joaquin | CEO And Chairman Of The Board | Sell | 100,000 | $221.23 | $22,122,893.44 | -47.5% | - | - | |
| Nov 26, 2025 | Johnson & Johnson59 | 10% Owner | Sell | 6,337 | $10.03 | $63,560.11 | -0.2% | +18.7% | - | |
| Nov 26, 2025 | Morikis John G64 | Director | Buy | 1,250 | $206.15 | $257,687.50 | +208.9% | +18.7% | - | |
| Nov 24, 2025 | Johnson & Johnson59 | 10% Owner | Sell | 2,700 | $10.05 | $27,132.00 | - | +19.3% | - | |
| Nov 12, 2025 | Johnson & Johnson59 | 10% Owner | Sell | 1,000 | $10.00 | $10,000.00 | - | +22.6% | - | |
| Nov 7, 2025 | Johnson & Johnson59 | 10% Owner | Sell | 52,532 | $10.21 | $536,309.72 | -0.6% | +27.5% | - | |
| Oct 17, 2025 | Reed John C | EVP, Innovative Medicine, R&D | Sale+OE | 21,721 | $192.71 | $4,185,793.09 | -67.1% | +13.6% | - |